Nolato AB (publ)
Research Nolato AB (publ) (NOLA-B) on Bullrun: valuation model: 28.5% undervalued, market cap SEK 12.82B, P/E 16.9, dividend yield 3.5%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerNOLA-B
- ExchangeST
- CountrySweden
- SectorHealthcare
- IndustryMedical Devices
- CurrencySEK
- Valuation signal28.5% undervalued
- Market capSEK 12.82B
- P/E16.9
- Dividend yield3.5%
- Financial periodFY2024
- RevenueSEK 9.66B
- Revenue growth1.2%
- Net incomeSEK 658.00M
- Free cash flowSEK 742.00M
- Gross margin16.7%
Valuation Snapshot
Bullrun's latest valuation model marks Nolato AB (publ) as 28.5% undervalued; latest market cap is SEK 12.82B; P/E is 16.9; dividend yield is 3.5%.
About Nolato AB (publ)
Nolato AB (publ) develops, manufactures, and sells plastic, silicone, and thermoplastic elastomer products in Europe, Asia, North America, and internationally. It operates through the Medical Solutions and Engineered Solutions segments. The company offers catheter balloons; breathing bags; non-conductive sealing and damping silicone products; primary plastic packaging for medicines; and crimp and dropper bottles. It also provides thermal heating pads, gap fillers, and paste under the Compatherm brand;
Frequently asked questions
Is Nolato AB (publ) overvalued or undervalued?
Bullrun's valuation model currently marks Nolato AB (publ) as 28.5% undervalued.
What is Nolato AB (publ)'s market cap?
Nolato AB (publ)'s market capitalization is SEK 12.82B.
What is Nolato AB (publ)'s P/E ratio?
Nolato AB (publ)'s price-to-earnings (P/E) ratio is 16.9.
Does Nolato AB (publ) pay a dividend?
Nolato AB (publ) has a dividend yield of 3.5%.
What does Nolato AB (publ) do?
Nolato AB (publ) develops, manufactures, and sells plastic, silicone, and thermoplastic elastomer products in Europe, Asia, North America, and internationally. It operates through the Medical Solutions and Engineered Solutions segments. The company offers catheter balloons; breathing bags;